» Articles » PMID: 33445522

In Situ "Humanization" of Porcine Bioprostheses: Demonstration of Tendon Bioprostheses Conversion into Human ACL and Possible Implications for Heart Valve Bioprostheses

Overview
Date 2021 Jan 15
PMID 33445522
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

This review describes the first studies on successful conversion of porcine soft-tissue bioprostheses into viable permanently functional tissue in humans. This process includes gradual degradation of the porcine tissue, with concomitant neo-vascularization and reconstruction of the implanted bioprosthesis with human cells and extracellular matrix. Such a reconstruction process is referred to in this review as "humanization". Humanization was achieved with porcine bone-patellar-tendon-bone (BTB), replacing torn anterior-cruciate-ligament (ACL) in patients. In addition to its possible use in orthopedic surgery, it is suggested that this humanization method should be studied as a possible mechanism for converting implanted porcine bioprosthetic heart-valves (BHV) into viable tissue valves in young patients. Presently, these patients are only implanted with mechanical heart-valves, which require constant anticoagulation therapy. The processing of porcine bioprostheses, which enables humanization, includes elimination of α-gal epitopes and partial (incomplete) crosslinking with glutaraldehyde. Studies on implantation of porcine BTB bioprostheses indicated that enzymatic elimination of α-gal epitopes prevents subsequent accelerated destruction of implanted tissues by the natural anti-Gal antibody, whereas the partial crosslinking by glutaraldehyde molecules results in their function as "speed bumps" that slow the infiltration of macrophages. Anti-non gal antibodies produced against porcine antigens in implanted bioprostheses recruit macrophages, which infiltrate at a pace that enables slow degradation of the porcine tissue, neo-vascularization, and infiltration of fibroblasts. These fibroblasts align with the porcine collagen-fibers scaffold, secrete their collagen-fibers and other extracellular-matrix (ECM) components, and gradually replace porcine tissues degraded by macrophages with autologous functional viable tissue. Porcine BTB implanted in patients completes humanization into autologous ACL within ~2 years. The similarities in cells and ECM comprising heart-valves and tendons, raises the possibility that porcine BHV undergoing a similar processing, may also undergo humanization, resulting in formation of an autologous, viable, permanently functional, non-calcifying heart-valves.

Citing Articles

Xenograft bone-patellar tendon-bone ACL reconstruction: a case series at 20-year follow-up as proof of principle.

Stone K, Walgenbach A, Turek T, Crues J, Galili U J Exp Orthop. 2023; 10(1):91.

PMID: 37672199 PMC: 10482801. DOI: 10.1186/s40634-023-00651-7.


Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine.

Kasravi M, Ahmadi A, Babajani A, Mazloomnejad R, Hatamnejad M, Shariatzadeh S Biomater Res. 2023; 27(1):10.

PMID: 36759929 PMC: 9912640. DOI: 10.1186/s40824-023-00348-z.


Advances in Regenerative Sports Medicine Research.

Wang L, Jiang J, Lin H, Zhu T, Cai J, Su W Front Bioeng Biotechnol. 2022; 10:908751.

PMID: 35646865 PMC: 9136559. DOI: 10.3389/fbioe.2022.908751.


Can Heart Valve Decellularization Be Standardized? A Review of the Parameters Used for the Quality Control of Decellularization Processes.

Naso F, Gandaglia A Front Bioeng Biotechnol. 2022; 10:830899.

PMID: 35252139 PMC: 8891751. DOI: 10.3389/fbioe.2022.830899.

References
1.
McGregor C, Carpentier A, Lila N, Logan J, Byrne G . Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves. J Thorac Cardiovasc Surg. 2010; 141(1):269-75. DOI: 10.1016/j.jtcvs.2010.08.064. View

2.
Cooper D, Good A, Koren E, Oriol R, Malcolm A, Ippolito R . Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol. 1993; 1(3):198-205. DOI: 10.1016/0966-3274(93)90047-c. View

3.
Muchmore E, Diaz S, Varki A . A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol. 1998; 107(2):187-98. DOI: 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.0.CO;2-S. View

4.
Zhu A, Hurst R . Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation. 2002; 9(6):376-81. DOI: 10.1034/j.1399-3089.2002.02138.x. View

5.
Park C, Park S, Choi S, Yoon S, Kim W, Kim Y . Anti alpha-gal immune response following porcine bioprosthesis implantation in children. J Heart Valve Dis. 2010; 19(1):124-30. View